45 related articles for article (PubMed ID: 38342870)
1. The clinical significance of systemic immune-inflammation index and platelet/neutrophil to lymphocyte ratio in Guillain-Barré syndrome.
Liu T; Gao J; Liu M
Clin Neurol Neurosurg; 2023 Dec; 235():108015. PubMed ID: 37898029
[TBL] [Abstract][Full Text] [Related]
2. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome.
Yao J; Zhou R; Liu Y; Liu Y; Cao Q; Lu Z
Neurol Ther; 2023 Dec; 12(6):2121-2132. PubMed ID: 37792219
[TBL] [Abstract][Full Text] [Related]
3. Association of CSF Total Protein with Clinical Heterogeneity, Disease Severity and Electrophysiological Pattern in GBS Patients.
Rahaman H; Rahman HZ; Emran MM; Rahman MA
Mymensingh Med J; 2024 Apr; 33(2):496-500. PubMed ID: 38557532
[TBL] [Abstract][Full Text] [Related]
4. Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.
van Tilburg SJ; Teunissen CE; Maas CCHM; Thomma RCM; Walgaard C; Heijst H; Huizinga R; van Doorn PA; Jacobs BC
EBioMedicine; 2024 Apr; 102():105072. PubMed ID: 38518653
[TBL] [Abstract][Full Text] [Related]
5. The analysis of serum lipids profile in Guillain-Barre syndrome.
Wang L; Ding Y; Liu J; Zheng G; Li S; Jiang W; Chen K; Luan X; Chen Y; Wang S; Zhang G
Front Immunol; 2023; 14():1301577. PubMed ID: 38143756
[TBL] [Abstract][Full Text] [Related]
6. Radiologic grading scores enhance clinical model's prognostic ability for Guillain-Barré syndrome.
Fang Q; Wu D; Wang B; Cao L; Cai S; Sun X; He J
Ann Clin Transl Neurol; 2024 Mar; 11(3):641-649. PubMed ID: 38158793
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome: A comprehensive review.
Bellanti R; Rinaldi S
Eur J Neurol; 2024 May; ():e16365. PubMed ID: 38813755
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor regarding "Immune-inflammation mapping in Guillain-Barré syndrome".
Berciano J
Clin Neurol Neurosurg; 2024 Feb; 237():108056. PubMed ID: 38364491
[No Abstract] [Full Text] [Related]
9. COVID-19 was found in a patient's cerebrospinal fluid who presented with a severe form of Guillain-Barre syndrome; A successful Sudanese story: Case report.
Ibrahim EAA; Mohamed Ahmed KAH; Salah ET; Omer MEA
Clin Case Rep; 2021 Aug; 9(8):e04597. PubMed ID: 34466239
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Teleconsultation-Based Rehabilitation in Children with Landry-Guillain-Barré Syndrome: An Open Label Randomized Controlled Trial (Tele Rehab-LGBS Trial).
Pravallika R; Suthar R; Patil A; Malviya M; Saxena S; Saini L; Bansal A
Indian J Pediatr; 2024 May; 91(5):455-462. PubMed ID: 37889455
[TBL] [Abstract][Full Text] [Related]
11. Immune-inflammation mapping in Guillain-Barré syndrome: Further insights.
Magoon R
Clin Neurol Neurosurg; 2023 Dec; 235():108028. PubMed ID: 37939620
[No Abstract] [Full Text] [Related]
12. Assessment of Serum Inflammatory Markers and their Correlation with Clinical Severity and Electrophysiological Subtypes of Guillain Barre Syndrome, and Investigating their Use as Prognostic Markers of Guillain Barre Syndrome.
Paneyala S; Naseer A; Iyer M; Gopi A
Ann Indian Acad Neurol; 2024; 27(1):101-103. PubMed ID: 38495232
[No Abstract] [Full Text] [Related]
13. Anaesthesia in a diagnosed ventricular septal defect with Guillain-Barré paediatric patient for videoassisted thoracic surgery.
Tomar GS; Sethi A; Kriplani T; Agrawal S
Indian J Anaesth; 2010 Jul; 54(4):345-6. PubMed ID: 20882181
[TBL] [Abstract][Full Text] [Related]
14. Reply: Peripherin is a biomarker of axonal damage in Guillain-Barré syndrome: a pathophysiological annotation.
Keddie S; Smyth D; Keh RYS; Wieske L; Michael M; Eftimov F; Bellanti R; Rinaldi S; Petzold A; Lunn MP
Brain; 2024 Jan; 147(1):e3-e4. PubMed ID: 37647107
[No Abstract] [Full Text] [Related]
15. Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome.
Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Nov; 92(1):4. PubMed ID: 33154185
[No Abstract] [Full Text] [Related]
16. Guillain-Barré syndrome in a man presenting with upper extremity monoplegia.
Gowan JM; Golla A; Liu A
Clin Case Rep; 2020 Apr; 8(4):593-597. PubMed ID: 32274017
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Guillain-Barré Syndrome: Clinical Profile and Outcome - Correspondence.
Finsterer J
Indian J Pediatr; 2024 Mar; ():. PubMed ID: 38483748
[No Abstract] [Full Text] [Related]
18. Recurrent Guillain-Barré Syndrome: Clinical Profile and Outcome - Authors' Reply.
Randhawa MS; Bansal A
Indian J Pediatr; 2024 Mar; ():. PubMed ID: 38492166
[No Abstract] [Full Text] [Related]
19. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.
Bano S; Nawaz A; Nasim A; Numan A; Zahid M
J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
